Amedica out of Salt Lake City, Utah won approval from European regulators to market the Valeo C and Valeo TL spinal intervertebral spacers made out of the firm’s proprietary silicon nitride ceramic.
The Valeo family of ceramic spinal intervertebral spacers is intended to aid in surgical correction and stabilization of the thoracolumbar spine. These implants are designed to restore the biomechanical integrity of the anterior, middle and posterior spine, even in the absence of fusion, for a prolonged period of time. The Valeo family of spacers provides new functionalities compared to competing devices currently on the market and is believed to be the first family of silicon nitride ceramic implants available for spinal use in the world.
“Amedica’s ceramic spinal spacers uniquely combine strength with an improved bone/implant interface and bone like imaging compatibility, making them a valuable alternative to currently available devices using conventional synthetic materials,” said Darrel Brodke, M.D., Professor and Vice-Chair, Director of Spine Service, Department of Orthopaedics, University of Utah School of Medicine. “Because these implants have a combination of distinguishing features, I would expect Amedica’s implants to be well received in Europe and Asia, where allograft bone is not frequently used.”
Product pages: Valeo C and Valeo TL
Amedica technology…
Press release: Amedica Receives CE MARK FOR THE WORLD’S FIRST FDA-CLEARED VALEO™ CERAMIC SPINAL IMPLANT SYSTEM…
